15Macrophages are infected by HIV-1 in vivo and contribute to both viral spread and 16 pathogenesis. Recent human and animal studies suggest that HIV-1-infected macrophages 17 serve as a reservoir that contributes to HIV-1 persistence during anti-retroviral therapy. This 18 phenomenon may be influenced by the local tissue microenvironment, including interactions 19 with commensal and pathogenic microbes. These effects are thought to result, in part, from 20 engagement of Toll-like receptors (TLRs); however, the effects of TLR signaling on virus 21 replication in macrophages are not fully understood. We wished to determine if the sexually 22 transmitted pathogen Neisseria gonorrhoeae (GC) and the gut-associated microbe Escherichia 23 coli (E. coli), which encode ligands for TLR2 and TLR4, repress HIV-1 replication in 24 macrophages and thereby induce a state of viral latency. We found that purified TLR ligands 25 that signal exclusively through the adapter MyD88 activated HIV-1 expression in macrophages, 26 whereas TLR ligands that signal through TRIF repressed HIV-1 expression. Inhibiting TLR4 27 signaling, blocking type 1 interferon, and knocking-down TRIF reversed LPS-and GC-mediated 28 repression of HIV-1. Finally, TLR4-mediated repression of HIV-1 in macrophages was 29 associated with the recruitment of interferon regulatory factor 8 (IRF8) to the interferon 30 stimulated response element (ISRE) downstream of the 5' LTR. Our data indicate that IRF8 is 31 responsible for repression of HIV-1 replication in macrophages in response to the TRIF-32 dependent signaling during GC and E. coli co-infection. These findings highlight the potential